Texas Tech Neuroimaging Institute
About Texas Tech Neuroimaging Institute
Texas Tech University is a public research university in Lubbock, Texas. Established on February 10, 1923, and called Texas Technological College until 1969, it is the main institution of the five-institution Texas Tech University System.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Texas Tech Neuroimaging Institute
During the past decade, Texas Tech Neuroimaging Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
2015-12-18
2018-08-21
Completed
383
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746
Zimura in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
2016-01-01
2020-04-23
Completed
286
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
2016-09-28
2019-05-13
Completed
147
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
2017-04-19
2021-07-20
Completed
500
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Tech Neuroimaging Institute"
#1 collaborator was "American Egg Board" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Texas Tech Neuroimaging Institute
According to Clinical.Site data, the most researched conditions in "Texas Tech Neuroimaging Institute" are
"Adolescents With Food Insecurity" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Texas Tech Neuroimaging Institute" in a lesser frequency.
Clinical Trials Intervention Types at Texas Tech Neuroimaging Institute
Most popular intervention types in "Texas Tech Neuroimaging Institute" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Increased Egg Consumption" (1 trials), "Placebo" (1 trials), "Saxenda®" (1 trials) and "Typical diet" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Tech Neuroimaging Institute
The vast majority of trials in "Texas Tech Neuroimaging Institute" are
2 trials for "All" genders.
Clinical Trials Status at Texas Tech Neuroimaging Institute
Currently, there are NaN active trials in "Texas Tech Neuroimaging Institute".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Texas Tech Neuroimaging Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Texas Tech Neuroimaging Institute, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".